Skin cancer 'vaccine implant' trial begins in America

Researchers in the United States are beginning human trials of a vaccine implant which targets skin cancer.

The implant is placed under the skin and re-programmes a patient's immune system to destroy cancerous melanoma cells.

Emily Thomas reports.